THE BLOG

Expert views on Analgesic News

All Posts

Mar 9
3 min

Vertex unlikely to repeat their CF success in Pain as they lack a personalized analgesics® approach.

Vertex are looking to other therapeutic areas to repeat their undoubted success in Cystic Fibrosis and create a sustainable pipeline....

62 views0 comments

How to improve innovation in analgesic development: Poster presented at IASP virtual Meeting 2020.

mark field

Sep 4, 2020
1 min

How to improve innovation in analgesic development: Poster presented at IASP virtual Meeting 2020.

Increasing innovation within analgesic R&D is key to identify new treatment options for millions of pain patients. I am delighted...

138 views0 comments

Peripherally acting phase 1 pain drug acquired in $940Million deal.

mark field

Aug 26, 2020
1 min

Peripherally acting phase 1 pain drug acquired in $940Million deal.

Yesterday (25th Aug 2020) saw the announcement that ACADIA Pharmaceuticals acquires privately held Dallas, TX-based CerSci Therapeutics,...

254 views0 comments

Unity Bio's novel pain drug fails in OA. Did they miss out by not using a precision approach?

mark field

Aug 18, 2020
2 min

Unity Bio's novel pain drug fails in OA. Did they miss out by not using a precision approach?

"Unity Biotechnology announced the 12-week results from the Phase 2 study of UBX0101, a p53/MDM2 interaction inhibitor, in patients with...

83 views0 comments

FDA approves Trevena’s Mu opioid for Acute pain.

mark field

Aug 11, 2020
2 min

FDA approves Trevena’s Mu opioid for Acute pain.

Back in January 2020 the FDA had a number of expert panels voting on opioid drugs – ultimately giving negative feedback for the class. So...

227 views0 comments

NICE guidance on chronic pain could prevent patients receiving life altering treatments

mark field

Aug 7, 2020
2 min

NICE guidance on chronic pain could prevent patients receiving life altering treatments

Nice guidance on chronic pain creates wrong messages and potentially stops patients receiving life altering medication. This week NICE...

166 views0 comments

P2X3 cough drug: Negative Ph II = 70% loss of stock price but severe patient group may show the way.

mark field

Jul 7, 2020
2 min

P2X3 cough drug: Negative Ph II = 70% loss of stock price but severe patient group may show the way.

Targeting the right patient population in clinical trials is key to avoiding a false negative and giving a medicine the best chance of...

104 views0 comments

Biogen ready to write-off Nav1.7 assets in pain?

mark field

May 26, 2020
3 min

Biogen ready to write-off Nav1.7 assets in pain?

The last annual report for Biogen indicates worrying signs for the future development of the latest stage Nav1.7 compound Vixotrigine.

845 views0 comments

Revolutionising pain R&D by developing Precision Analgesics

mark field

May 12, 2020
1 min

Revolutionising pain R&D by developing Precision Analgesics

Presentation by Mark J. Field at SMI Pain Therapeutics Meeting 12th May 2020. You can find a copy of the presentation above. It covers...

127 views0 comments

COVID19: creating a new era for 'Citizen Science'

mark field

Apr 20, 2020
4 min

COVID19: creating a new era for 'Citizen Science'

"Citizen science" is defined as "scientific work undertaken by members of the general public, often in collaboration with or under the...

29 views0 comments

P2X3 receptor antagonists pass Phase 3 trials for cough – potential also in pain?

mark field

Mar 20, 2020
2 min

P2X3 receptor antagonists pass Phase 3 trials for cough – potential also in pain?

P2X3 receptor channels are attractive therapeutic targets as they are expressed in sensory neurons, activated by extracellular ATP and...

198 views0 comments

Which companies are interested in Pain? The useful analytics below LinkedIn likes & comments.

mark field

Mar 17, 2020
2 min

Which companies are interested in Pain? The useful analytics below LinkedIn likes & comments.

I believe LinkedIn is a great source for keeping up to date with content which can be tailored to be most relevant to you. Over the past...

153 views0 comments

Is this still a relevant target for new pain treatments: the α2δ (Alpha2Delta) Ca2+ channel?

mark field

Feb 21, 2020
3 min

Is this still a relevant target for new pain treatments: the α2δ (Alpha2Delta) Ca2+ channel?

The traditional approach to analgesic development could be described as 'exceptionally challenging', with a clinical success rate of...

104 views0 comments

Has a new study found a personalized approach for Nav1.7? 'Precision Analgesics' may be a better bet

mark field

Feb 10, 2020
4 min

Has a new study found a personalized approach for Nav1.7? 'Precision Analgesics' may be a better bet

The difficulties of pain research are highlighted well by the tale of the Nav1.7 sodium channel, which was thought to be the ‘holy grail’...

77 views0 comments

So Pfizer & Lilly do ask FDA to approve Tanezumab for OA pain...

mark field

Feb 6, 2020
3 min

So Pfizer & Lilly do ask FDA to approve Tanezumab for OA pain...

Just a few months ago some commentators had pronounced the death of Tanezumab and the whole anti-NGF class it leads, following years of...

296 views0 comments

Vertex discontinues development of its Nav1.8 pain drug VX-961.

mark field

Feb 3, 2020
2 min

Vertex discontinues development of its Nav1.8 pain drug VX-961.

Deep within the Full-Year and Fourth-Quarter 2019 Financial Results for Vertex you can find this statement: “Pain: The company announced...

1,441 views0 comments

Big data & human biomarkers – the era of citizen scientists

mark field

Jan 28, 2020
2 min

Big data & human biomarkers – the era of citizen scientists

The probability of a new analgesic making it through clinical development is 2%. Five-times lower than other therapeutic areas. This...

22 views0 comments

Approval of new pain drug shows the path for analgesic innovation

mark field

Jan 28, 2020
2 min

Approval of new pain drug shows the path for analgesic innovation

The new Novartis medicine Adakveo® (crizanlizumab)has just been approved by the FDA to reduce frequency of pain crises in individuals...

63 views0 comments

Patient-Inspired R&D – the missing part of patient engagement

mark field

Jan 28, 2020
3 min

Patient-Inspired R&D – the missing part of patient engagement

Patient engagement is the ‘hot topic’ within the pharma industry over the last few years, with every company, Biotech, CRO and consultant...

26 views0 comments

{"items":["6047835546f8c4001558064d","5f51fe141f5b870018dc73f8","5f4634ef76163b0017b52ed5","5f3bed2e3c48e00017dcddff","5f328e2608c9b200188dc83d","5f2d229800ac55001754208d","5f0480cac560550017b3af7c","5ecce94ab14cc70017d090dc","5ebac325e9c50300170a1a29","5e9dec360c2bba0017e5f659","5e74b9f054d25a001766fa53","5e70ebd2f1f43b0017def04e","5e4fa2e26edacc00176d0bf0","5e4179f04178f50017227982","5e3c00c7fc54180017854727","5e382a7ddedd8e001724de44","5e30bf597b22bb0017cb8750","5e30bde8eb283900170b0c77","5e30514170f058001703260c"],"styles":{"galleryType":"Columns","groupSize":1,"showArrows":true,"cubeImages":true,"cubeType":"fill","cubeRatio":1.3333333333333333,"isVertical":true,"gallerySize":30,"collageAmount":0,"collageDensity":0,"groupTypes":"1","oneRow":false,"imageMargin":32,"galleryMargin":0,"scatter":0,"rotatingScatter":"","chooseBestGroup":true,"smartCrop":false,"hasThumbnails":false,"enableScroll":true,"isGrid":true,"isSlider":false,"isColumns":false,"isSlideshow":false,"cropOnlyFill":false,"fixedColumns":1,"enableInfiniteScroll":true,"isRTL":false,"minItemSize":50,"rotatingGroupTypes":"","rotatingCropRatios":"","columnWidths":"","gallerySliderImageRatio":1.7777777777777777,"numberOfImagesPerRow":1,"numberOfImagesPerCol":1,"groupsPerStrip":0,"borderRadius":0,"boxShadow":0,"gridStyle":1,"mobilePanorama":false,"placeGroupsLtr":true,"viewMode":"preview","thumbnailSpacings":4,"galleryThumbnailsAlignment":"bottom","isMasonry":false,"isAutoSlideshow":false,"slideshowLoop":false,"autoSlideshowInterval":4,"bottomInfoHeight":0,"titlePlacement":"SHOW_ON_THE_RIGHT","galleryTextAlign":"center","scrollSnap":false,"itemClick":"nothing","fullscreen":true,"videoPlay":"hover","scrollAnimation":"NO_EFFECT","slideAnimation":"SCROLL","scrollDirection":0,"scrollDuration":400,"overlayAnimation":"FADE_IN","arrowsPosition":0,"arrowsSize":23,"watermarkOpacity":40,"watermarkSize":40,"useWatermark":true,"watermarkDock":{"top":"auto","left":"auto","right":0,"bottom":0,"transform":"translate3d(0,0,0)"},"loadMoreAmount":"all","defaultShowInfoExpand":1,"allowLinkExpand":true,"expandInfoPosition":0,"allowFullscreenExpand":true,"fullscreenLoop":false,"galleryAlignExpand":"left","addToCartBorderWidth":1,"addToCartButtonText":"","slideshowInfoSize":200,"playButtonForAutoSlideShow":false,"allowSlideshowCounter":false,"hoveringBehaviour":"NEVER_SHOW","thumbnailSize":120,"magicLayoutSeed":1,"imageHoverAnimation":"NO_EFFECT","imagePlacementAnimation":"NO_EFFECT","calculateTextBoxWidthMode":"PERCENT","textBoxHeight":0,"textBoxWidth":200,"textBoxWidthPercent":50,"textImageSpace":10,"textBoxBorderRadius":0,"textBoxBorderWidth":0,"loadMoreButtonText":"","loadMoreButtonBorderWidth":1,"loadMoreButtonBorderRadius":0,"imageInfoType":"ATTACHED_BACKGROUND","itemBorderWidth":1,"itemBorderRadius":0,"itemEnableShadow":false,"itemShadowBlur":20,"itemShadowDirection":135,"itemShadowSize":10,"imageLoadingMode":"BLUR","expandAnimation":"NO_EFFECT","imageQuality":90,"usmToggle":false,"usm_a":0,"usm_r":0,"usm_t":0,"videoSound":false,"videoSpeed":"1","videoLoop":true,"jsonStyleParams":"","gallerySizeType":"px","gallerySizePx":940,"allowTitle":true,"allowContextMenu":true,"textsHorizontalPadding":-30,"itemBorderColor":{"value":"#BFBFBF"},"showVideoPlayButton":true,"galleryLayout":2,"targetItemSize":940,"selectedLayout":"2|bottom|1|fill|true|0|true","layoutsVersion":2,"selectedLayoutV2":2,"isSlideshowFont":false,"externalInfoHeight":0,"externalInfoWidth":0.5},"container":{"width":940,"galleryWidth":972,"galleryHeight":0,"scrollBase":0,"height":null}}